Anti-FIXa x Anti-FX Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-FIXa and anti-FX parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy.
There are currently no customer reviews or questions for Human Anti-FIXa x Anti-FX Bispecific Antibody (IgG-IgG) (BSIG-H327). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS